Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome

Circulation

Volumn 97, Issue 5, 1998, Pages 451-456

  Rashba, Eric J ^c   Zareba, Wojciech ^b   Moss, Arthur J ^c   Jackson Hall, W ^c   Robinson, Jennifer ^c   Locati, Emanuela H ^c   Schwartz, Peter J ^a   Andrews, Mark ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c NONE

Author keywords

Cardiovascular diseases; Long QT syndrome; Pregnancy

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SYNCOPE;

EID: 0032502041     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.5.451     Document Type: Article

References (41)

1. Elkayam U. Pregnancy and cardiovascular disease. In: Braunwald EG, ed. Heat Disease: A Textbook of Cardiovascular Medicine. Philadelphia, Pa: WB Saunders Co: 1992;1790-1809.
2. Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A. Effect of pregnancy on supraventricular tachycardia. Am J Cardiol. 1993;72:838-840.
3. Lee Sh, Chen SA, Wu TJ, Chiang CE, Cheng CC, Tai CT, Chiou CW, Ueng KC, Chang MS. Effects of pregnancy on first-onset of paroxysmal supraventricular tachycardia. Am J Cardiol. 1995;76:675-678.
4. Wilkinson C, Gyaneshwar R, McKusker C. Twin pregnancy in a patient with idiopathic long QT syndrome: case report. Br J Obstet Gynaecol. 1991;98:1300-1302.
5. McCurdy CM, Rutherford SE, Coddington CC. Syncope and sudden arrhythmic death complicating pregnancy: a case report of Romano-Ward Syndrome. J Reprod Fertil. 1995;40:725-728.
6. Plotz J, Heidegger H, von Hugo R, Grohmann H, Deeg KH. Hereditary prolonged QT interval (Romano-Ward Syndrome) in a female patient with non-elective caesarian section. Anaesthetist. 1992;41:88-92.
7. Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E. The long QT syndrome: a prospective international study. Criculation. 1985;71:17-21.
8. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitcamp L, Vincent GM, Garson A, Robinson JL, Benhorin J, Choi S. Long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136-1144.
9. Bazett HC. An analysis of the time relations of electrocardiograms. Heart. 1920;7:353-367.
10. Moss AJ, Benhorin J. QT interval prolongation: basic considerations and clinical consequences. In: Braunwald EG ed. In: Braunwald EG, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia. Pa: WB Saunders Co: 1993:1-9.
11. Schwartz PJ, Periti M, Malliani A. The long QT syndrome. Am Heart J. 1975;89:378-390.
12. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399-411.
13. Schwartz PJ, Locati E. The idiopathic long QT syndrome: pathogenetic mechanisms and therapy. Eur Heart J. 1985;6(suppl D):103-114.
14. Klangkalya B, Chan A. The effects of ovarian hormones on beta-adrenergic and muscarinic receptors in rat heart. Life Sci. 1988;42:2307-2314.
15. Wilkinson M, Herdon H, Pearce M, Wilson C. Radioligand binding studies on hypothalamic noradrenergic receptors during the estrous cycle or after steroid injection in ovariectomized rats. Brain Res. 1979;168:652-655.
16. Etgen AM, Karkanias GB. Estrogen regulation of noradrenergic signaling in the hypothalamus. Psychoneuroendocrinology. 1994;19:603-610.
17. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795-803.
18. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of A novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17-23.
19. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805-811.
20. Merri M. Moss AJ, Benhorin J, Locati E, Alberti M, Badilini F. Relation between ventricular repolarization duration and cardiac cycle length during 24-hour Holter recordings: findings in normal patients and patients with long QT syndrome. Circulation. 1992;85:1816-1821.
21. Frishman WH, Chesner M. Beta-adrenergic blockers in pregnancy. Am Heart J. 1988;115:147-152.
22. Cox JL, Gardner M. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis. 1993;36:137-138.
23. Rotmensch HH, Elkayam U, Frishman W. Antiarrhythmic drug therapy during pregnancy. Ann Int Med. 1983;98:487-497.
24. Cotrill CM, McAllister RG, Gettes L, Noonan JA. Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition. J Pediatr. 1977;91:812-814.
25. Habib A, McCarthy JS. Effects on the neonate of propranolol administration during pregnancy. J Pediatr. 1977;91:808-811.
26. Turnstall MB. The effect of propranolol on the onset of breathing at birth. Acta Obstet Gynecol Scand. 1984;63:199-202.
27. Eliahou HE, Silverberg DS, Reisin E, Romem I, Mashiach S, Serr DM. Propranolol for the treatment of hypertension in pregnancy. Br J Obstet Gynaecol. 1978;85:431-436.
28. Bott-Kanner G, Schweitzer A, Reisner SH, Joel-Cohen SJ, Rosenfeld JB. Propranolol and hydralazine in the management of essential hypertension in pregnancy. Br J Obstet Gynaecol. 1980;87:110-114.
29. Tcherdakoff PH, Colliard M, Berrard E, Kreft C, Dupay A, Bernaille JM. Propranolol in hypertension during pregnancy. BMJ. 1978;2:670.
30. Oakley CDG, McGary K, Limb DG, Oakley CM. Management of pregnancy in patients with hypertrophic cardiomyopathy. BMJ. 1979;1:1749-1750.
31. Gladstone GR, Hordof A, Gerson WM. Propranolol administration during pregnancy: effects on the fetus. J Pediatr. 1975;86:962-964.
32. Rubin PC, Butters L, Low RA, Reid JL. Atenolol in the treatment of essential hypertension during pregnancy. Br J Clin Pharmacol. 1982;14:279-281.
33. Sandstrom B. Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Obstet Invest. 1978;9:195-204.
34. Karlberg B, Lundberg D, Aberg H. Excretion of propranolol in human breast milk. Acta Pharmacol Toxicol. 1974;32:222-224.
35. Bauer JH, Pape B, Zajicek J, Groshong T. Propranolol in human plasma and breast milk. Am J Cardiol. 1979;43:860.
36. Levitan AA, Manion JC. Propranolol therapy during pregnancy and lactation. Am J Cardiol. 1973;32:247.
37. Liedholm H, Melander A, Bitzen P-O, Helm G, Lonnerholm G, Mattiason I, Nilsson B, Wahlin-Boll E. Accumulation of metoprolol and atenolol in human breast milk. Eur J Clin Pharmacol. 1982;20:229-231.
38. Scimmel MS, Eidelman AJ, Wihchanski MA, Shaw D, Ogilvie RJ, Koren G. Toxic effects of atenolol consumed during breast feeding. J Pediatr. 1989;114:476-477.
39. Sandstrom B, Regardh C-G. Metoprolol excretion into breast milk. Br J Clin Pharmacol. 1980;9:195-204.
40. Taylor EA, Turner P. Antihypertensive therapy with propranolol during pregnancy and lactation. Postgrad Med J. 1981;57:427-430.
41. + channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation. 1995;92:3381-3386.